Varicella-Zoster-Comple Fix Antigen and Neg Contro

FDA 510(k) K852930 · Microbix Biosystems, Inc.

Substantially Equivalent

510(k) numberK852930

Submission

Device name
Varicella-Zoster-Comple Fix Antigen and Neg Contro
Applicant
Microbix Biosystems, Inc.
Canada, CA
Received
July 9, 1985
Decision date
November 12, 1985
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)

Official FDA 510(k) record

Device classification

Product code
GQX – Antiserum, Cf, Varicella-Zoster
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3900
Specialty
Microbiology

Other 510(k)s with product code GQX

510(k)DeviceApplicantDecision
K951799Varicella-Zoster Virus Direct Immunofluorescence AssayGQX · Traditional Light Diagnostics03/20/1996SE
K911301VZV Igm TestGQX · Traditional Gull Laboratories, Inc.07/17/1991SE
K883427Virgo(R) Vzv-Igg ElisaGQX · Traditional Electro-Nucleonics, Inc.03/10/1989SE
K875358VZV TestGQX · Traditional Gull Laboratories, Inc.03/31/1988SE
K863317Enzygnost Anti-Vzv Igg TestGQX · Traditional Behring Diagnostics, Inc.04/22/1987SE
K853540Fiax Test Kit for Varicella Antibody SerologyGQX · Traditional Idt, A Division of Whittaker M.A. Bioproducts02/04/1986SE
K842096GLB Varicella-Zoster Virus FluorescentGQX · Traditional Great Lakes Bioscience01/07/1985SE
K841526Ortho Varicella-Zoster Virus Ident.GQX · Traditional Ortho Diagnostic Systems, Inc.06/25/1984SE
K770810Varicella-Zoster Fa Labeled PreserumGQX · Traditional Flow Laboratories, Inc.05/20/1977SE
K770806Varicella-Zoster Fa Labelled (8-321 RF)GQX · Traditional Flow Laboratories, Inc.05/20/1977SE

More from Flow Laboratories, Inc.

510(k)DeviceDecision
K894262Rubella Antigen and Control AntigenGON · Traditional 10/16/1989SE
K894261Toxoplasma Gondii-Cf Antigen and Control AntigenGMN · Traditional 10/16/1989SE
K852932Measles-Complement Fix Antigen & Negative CLTGRF · Traditional 11/12/1985SE
K852931Herpes Hominus I-Comple Fix Antigen & Negative CLTGQO · Traditional 11/12/1985SE
K852929Cmv-Complement Fixation Antigen and Negative ContrGQI · Traditional 11/12/1985SE
K852933Mycoplasma SPP Serological ReagentsGSB · Traditional 08/01/1985SE

Questions and answers

When was Varicella-Zoster-Comple Fix Antigen and Neg Contro cleared by the FDA?

Varicella-Zoster-Comple Fix Antigen and Neg Contro (K852930) received a 510(k) decision of Substantially Equivalent on November 12, 1985, 126 days after the submission was received.

What is the product code of K852930?

The FDA product code is GQX – Antiserum, Cf, Varicella-Zoster, a Class II (moderate risk) device regulated under 21 CFR 866.3900.